The Medical Council of India (MCI) via amendment to the “Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulation 2002” has brought out the code of conduct for doctors and professional association of doctors in their relationship with pharmaceutical and allied health sector industry which prohibit them from accepting any gifts, travel facility or hospitality, from any phar...

This case examines the business development and strategic expansion of Greenway Medical Technologies, a software company delivering electronic healthcare solutions to physicians operating small practices. Over a period of seven years and with an investment of $70 million, Greenway built a best-in-class software application. The case also describes the electronic medical record systems industry ...

A panel of physicians from the Society for Academic Emergency Medicine (SAEM) Graduate Medical Education (GME), Ethics, and Industry Relations Committees were asked by the SAEM Board of Directors to write a position paper on the relationship of emergency medicine (EM) GME with industry. Using multiple sources as references, the team derived a set of guidelines that all EM GME training programs ...

Entrepreneurs in high technology industries often have prior experience at incumbent firms, but we know little about how knowledge obtained at the prior employer impacts entrepreneurial performance. Drawing on previous work from management, economics, and organizational sociology, I assess the impact of prior industry experience on entrepreneurial performance and innovation in medical device st...

Concerns about the influence of the pharmaceutical and medical device industries on continuing medical education (CME) have been voiced frequently over the past decade.1 Reliance on industry funding increases the potential for bias. Industry-supported CME often emphasizes conditions that can be treated with newer drugs or devices rather than those with the greatest public health impact, and ris...

1. The medical profession represented by the Standing Committee of European Doctors (CPME), and the pharmaceutical industry represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA), aware of their responsibilities vis-à-vis patients and society, consider it essential to establish a framework that can serve as guidelines at a European level as well as at a nat...

BACKGROUND Although industry sponsors provide approximately 70 percent of the funding for clinical drug trials in the United States, little is known about the legal agreements that exist between industry sponsors and academic investigators. We studied institutional standards regarding contractual provisions that restrict investigators' control over trials. METHODS We used a structured, cross-...